(Q43670521)

25 November 2017

A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion (English)

1 reference

25 November 2017

1 reference

Candida

1 reference

6

1 reference

25 November 2017

L D Liebowitz

1

1 reference

25 November 2017

H R Ashbee

2

1 reference

25 November 2017

E G Evans

3

1 reference

25 November 2017

Y Chong

4

1 reference

25 November 2017

N Mallatova

5

1 reference

25 November 2017

D Gibbs

7

1 reference

25 November 2017

Global Antifungal Surveillance Group

8

1 reference

25 November 2017

1 May 2001

1 reference

Diagnostic Microbiology and Infectious Disease

25 November 2017

1 reference

25 November 2017

40

1 reference

25 November 2017

1-2

1 reference

25 November 2017

27-33

1 reference

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Evaluation of the susceptibility of pathogenic Candida species to fluconazole. Fluconazole Global Susceptibility Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Fluconazole-resistant Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Fluconazole failure in the treatment of invasive mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Predominant pathogens in hospital infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Candida tropicalis and Candida albicans fungemia in children with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Global Antifungal Surveillance Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Treatment of systemic fungal infections: recent progress and current problems

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Hospital-acquired candidemia. The attributable mortality and excess length of stay

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900243-7

7 January 2021

10.1016/S0732-8893(01)00243-7

Identifiers

DOI

1 reference

25 November 2017

1 reference